Department of Emergency Medicine, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, NY.
Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass.
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2262-2269. doi: 10.1016/j.jaip.2019.04.004. Epub 2019 Apr 8.
Awareness about food allergy and food-induced anaphylaxis (FIA) has increased dramatically over the past decade. It remains unclear, however, whether concordance with guidelines for FIA management has improved over time.
Our objective was to describe changes in emergency department (ED) concordance with guidelines for FIA management.
We analyzed data from 2 multicenter retrospective studies of patients with food-related acute allergic reactions seen in 1 of 17 EDs during 2 time periods: 1999 to 2001 and 2013 to 2015. Visits were identified similarly across years-for example, using International Classification of Diseases, Ninth Revision, Clinical Modification codes 693.1, 995.60, 995.61-995.69, 995.0, and 995.3. Anaphylaxis was defined as an acute allergic reaction with involvement of 2+ organ systems or hypotension. We compared concordance between time periods for 4 guideline recommendations: (1) treatment with epinephrine, (2) discharge prescription for an epinephrine autoinjector (EAI), (3) referral to an allergist/immunologist, and (4) instructions to avoid offending allergen.
We compared 290 patients with FIA during 1999 to 2001 and 459 during 2013 to 2015. Any treatment with epinephrine (pre-ED or in the ED) for patients with FIA increased over time (38% vs 56%; P < .001). Prescriptions for EAI at discharge (24% vs 54%; P < .001) and documentation for referral to an allergist/immunologist (14% vs 24%; P = .001) approximately doubled, whereas instructions to avoid the offending allergen did not change significantly (37% vs 43%; P = .08). Receipt of 3+ guideline recommendations remained low but almost quadrupled over the study interval (6% vs 23%; P < .001).
Over the nearly 15-year study interval, we observed clinically and statistically significant increases in ED concordance with epinephrine-related guidelines for FIA. Management gaps remain and interventions to standardize care still appear warranted.
在过去的十年中,人们对食物过敏和食物诱发的过敏反应(FIA)的认识有了显著提高。然而,目前尚不清楚 FIA 管理指南的一致性是否随时间而有所改善。
我们的目的是描述急诊(ED)中 FIA 管理指南一致性的变化。
我们分析了 2 项多中心回顾性研究的数据,这些研究涉及在 17 个 ED 中的 1 个在 2 个时间段内就诊的与食物相关的急性过敏反应患者:1999 年至 2001 年和 2013 年至 2015 年。在不同年份中使用相同的方法来识别就诊,例如,使用国际疾病分类,第九版,临床修正版(ICD-9-CM)代码 693.1、995.60、995.61-995.69、995.0 和 995.3。过敏反应定义为涉及 2 个或更多器官系统的急性过敏反应或低血压。我们比较了 2 个时间段内的 4 项指南建议的一致性:(1)使用肾上腺素治疗,(2)开出处方使用肾上腺素自动注射器(EAI),(3)转介给过敏/免疫学家,以及(4)避免过敏原的指示。
我们比较了 1999 年至 2001 年期间的 290 例 FIA 患者和 2013 年至 2015 年期间的 459 例 FIA 患者。在 FIA 患者中,任何在 ED 前或 ED 内使用肾上腺素(急诊前或急诊内)的治疗方法均随时间增加(38%比 56%;P<0.001)。出院时开具 EAI 处方(24%比 54%;P<0.001)和记录转介给过敏/免疫学家(14%比 24%;P=0.001)的比例几乎翻了一番,而避免接触过敏原的指示并没有明显变化(37%比 43%;P=0.08)。收到 3 项以上指南建议的比例仍然很低,但在研究期间几乎翻了两番(6%比 23%;P<0.001)。
在近 15 年的研究期间,我们观察到 FIA 与肾上腺素相关指南的 ED 一致性方面出现了具有临床和统计学意义的显著提高。管理差距仍然存在,仍然需要采取干预措施来规范护理。